ArticleThe FEBS journal2026
Evolution of lysine and arginine biosynthesis revealed by substrate specificity of lysine biosynthetic enzymes in Thermus thermophilus.
Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Evolution of the First Code.Genes · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Metabolic pathways are considered to originate from broad-specificity ancestors that later diverged into specialized routes. Thermus thermophilus possesses an unusual amino group carrier protein (AmCP)-mediated lysine biosynthetic pathway alongside a canonical arginine biosynthetic pathway. Although each route is considered specific to its cognate amino acid, several lysine biosynthetic enzymes have been shown to accept arginine intermediates. We herein investigated [LysW]-aminoadipate kinase (LysZ; EC:2.7.2.17) and [LysW]-L-2-aminoadipate 6-phosphate reductase (LysY; EC:1.2.1.103), which catalyze the second and third steps, respectively, in the conversion of α-aminoadipate (AAA) to lysine using amino group carrier protein LysW (AmCP), to define their specificity and evolutionary origin. To examine the potential promiscuity, we engineered LysX variants capable of synthesizing LysW-Glu, an artificial LysW-bound analogue that mimics an arginine pathway intermediate. LysZ exhibited activity for LysW-Glu that was approximately 60% of the original activity for LysW-AAA. The activity of LysY for LysW-Glu phosphate was estimated to be approximately 15-20% of that observed with LysW-AAA phosphate. The present study revealed that both enzymes can also act on an arginine biosynthetic intermediate, but with distinct degrees of efficiency. Phylogenetic reconstructions further suggested that an AmCP-mediated biosynthetic pathway represents a primitive route for the synthesis of lysine and arginine in a primordial cell. More generally, the results obtained herein will contribute to a more detailed understanding of the evolutionary strategies employed by nature to specialize and expand metabolic pathways and adjust enzyme promiscuity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.